Oak Foundation Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2010
NCT01506804
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Oak Foundation

Active Ingredients

Drugs in Phase 2 Trials (1)

rosehip (1 trial)

Drugs in Other Trials (1)

methylprednisolone (medrol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2